Induction of fatty acid synthase and S14 gene expression by glucose, xylitol and dihydroxyacetone in cultured rat hepatocytes is closely correlated with glucose 6-phosphate concentrations.
It is now well established that the transcription of several genes belonging to the glycolytic and lipogenic pathway is stimulated in the presence of a high glucose concentration in adipocytes and hepatocytes. We have previously proposed that glucose 6-phosphate could be the signal metabolite that transduces the glucose effect. This proposal has recently been challenged and both an intermediate of the pentose phosphate pathway, xylulose 5-phosphate, and metabolites of the later part of glycolysis (3-phosphoglycerate and phosphoenolpyruvate) have been proposed. To discriminate between these possibilities, we have measured concomitantly, in primary cultures of adult rat hepatocytes, the expression of the fatty acid synthase (FAS) and S14 genes and the concentration of glucose metabolites. We have used various substrates entering at different steps of the glycolytic pathway (glucose, dihydroxyacetone) and the pentose phosphate pathway (xylitol). When compared with 5 mM glucose, 25 mM glucose induces a marked increase in both S14 and FAS gene expression, detectable as early as 2 h and peaking at 6 h. Increasing concentrations (1-5 mM) of xylitol and dihydroxyacetone in the presence of 5 mM glucose are also able to induce S14 and FAS gene expression progressively. Among the various glucose metabolites measured, glucose 6-phosphate, in contrast with xylulose 5-phosphate and metabolites of the lower part of glycolysis, is the only one that shows a clear-cut parallelism between its concentration and the degree of S14 and FAS gene expression. We conclude that glucose 6-phosphate is the most likely signal metabolite for the glucose-induced transcription of this group of genes.
Mourrieras
F
F
U342 INSERM, Hôpital Saint-Vincent-de-Paul, Paris, France.
Foufelle
F
F
Foretz
M
M
Morin
J
J
Bouche
S
S
Ferre
P
P
D000375:Aging; D000818:Animals; D002478:Cells, Cultured; D004098:Dihydroxyacetone / Q000494:pharmacology*; D004790:Enzyme Induction / Q000187:drug effects / Q000235:genetics; D064429:Fatty Acid Synthases / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D005941:Glucokinase / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology*; D019298:Glucose-6-Phosphate / Q000378:metabolism*; D006019:Glycolysis / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D009687:Nuclear Proteins; D011506:Proteins / Q000187:drug effects / Q000235:genetics*; D051381:Rats; D017208:Rats, Wistar; D014157:Transcription Factors; D014993:Xylitol / Q000494:pharmacology*
D009687:Nuclear Proteins; D011506:Proteins; C051065:THRSP protein, human; C501478:Thrsp protein, rat; D014157:Transcription Factors; D019298:Glucose-6-Phosphate; D064429:Fatty Acid Synthases; D005941:Glucokinase; D005947:Glucose; D004098:Dihydroxyacetone; D014993:Xylitol